Abstract:
Ethiopia has made great strides to improve access to safe, quality and efficacious pharmaceutical products
to the public. The EFDA is responsible for ensuring the safety, quality and efficacy of pharmaceutical products
circulating in the market. The availability of substandard and falsified (SF), and illegally circulating medicine
with unknown sources negatively impacts patient safety. In addition, the inefficient recall system, and lack
of visibility in pharmaceutical products movement among the pharmaceutical supply chain actors and
within organizations, hinders the supply chain from functioning efficiently. This has forced the government
to implement a system that ensures traceability of pharmaceutical products that spans from manufacturer to
end-users.
